Health
UK Scientists Celebrate Breakthrough Births Using Three-Person IVF to Prevent Genetic Disorders
In a significant scientific milestone, eight babies have been born in the United Kingdom using a pioneering fertility technique that combines DNA from three people. The innovation is designed to prevent the transmission of rare, potentially fatal mitochondrial diseases — and represents a major step forward in reproductive medicine.
The births were made possible by a 2016 change in UK law allowing the use of mitochondrial replacement therapy (MRT), a method still banned in countries like the United States but permitted in places such as Australia. Researchers from Newcastle University and Monash University, reporting in the New England Journal of Medicine, said the babies were born following IVF procedures involving 22 women. One additional pregnancy is ongoing.
“This marks an important milestone,” said Dr. Zev Williams, director of the Columbia University Fertility Centre in the U.S. “Expanding the range of reproductive options empowers more couples to pursue safe and healthy pregnancies.”
Mitochondrial disorders are caused by mutations in the small amount of DNA found in the mitochondria — the energy-producing structures in cells inherited only from the mother. These mutations can lead to severe conditions including seizures, muscle weakness, organ failure, and in some cases, death during infancy.
To prevent this, MRT replaces faulty mitochondria with healthy ones from a donor egg. The mother’s nucleus — which contains the vast majority of her genetic material — is transferred into a donor egg that has had its own nucleus removed. The result is an embryo with DNA from three individuals: the mother, the father, and a third donor, though the donor DNA accounts for less than 1% of the child’s total genetic material.
Experts caution that the procedure is only suitable for women at high risk of passing on mitochondrial diseases, particularly when traditional embryo screening methods are insufficient. One of the eight babies showed slightly elevated levels of abnormal mitochondria, but not enough to pose a health risk, researchers said.
Dr. Andy Greenfield of the University of Oxford called the research “a triumph of scientific innovation,” while stem cell specialist Robin Lovell-Badge emphasized that the small amount of donor DNA is far less than what would be found in procedures like bone marrow transplants.
To date, 35 families in the UK have received approval to use the technique, which is tightly regulated. However, concerns remain over the long-term effects of heritable genetic modifications, a key reason the U.S. has yet to permit clinical research on MRT.
For families affected by mitochondrial disease, the breakthrough brings renewed hope. Liz Curtis, who lost her daughter Lily to a mitochondrial disorder in 2006, called the development “super exciting.” Curtis now leads the Lily Foundation, which supports research into the disease, including the work at Newcastle.
“It’s hope for families that previously had none,” she said.
-
Entertainment2 years agoMeta Acquires Tilda Swinton VR Doc ‘Impulse: Playing With Reality’
-
Business2 years agoSaudi Arabia’s Model for Sustainable Aviation Practices
-
Business2 years agoRecent Developments in Small Business Taxes
-
Sports2 years agoChina’s Historic Olympic Victory Sparks National Pride Amid Controversy
-
Home Improvement1 year agoEffective Drain Cleaning: A Key to a Healthy Plumbing System
-
Politics2 years agoWho was Ebrahim Raisi and his status in Iranian Politics?
-
Sports2 years agoKeely Hodgkinson Wins Britain’s First Athletics Gold at Paris Olympics in 800m
-
Business2 years agoCarrectly: Revolutionizing Car Care in Chicago
